Brief: Repare Therapeutics Q1 Income From Operations USD 10.816 Million
07/05/2024 21:05
May 07 (Reuters) - Repare Therapeutics Q1 net income USD 13.162 million. * Q1 operating expenses USD 41.588 million * Q1 pretax profit USD 13.791 million
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln